Who Buys Ketorolac from India — 638 Importers Behind a $115.9M Market

The importers of Ketorolac from India can be categorized into several key segments:

1. Distributors: Entities such as EVERSANA LIFE SCIENCE SERVICES and J. KNIPPER & COMPANY in the United States fall into this category. These organizations purchase Ketorolac in bulk to supply to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders with a focus on maintaining a consistent supply chain to meet market demand.

2. Contract Manufacturers: Companies like BAXTER HEALTHCARE CORPORATION in the United States are contract manufacturers. They procure Ketorolac as an active pharmaceutical ingredient (API) to produce finished dosage forms under contract for other pharmaceutical companies. Their procurement patterns are aligned with production schedules and contractual obligations, often involving substantial quantities to ensure production efficiency.

3. Re-exporters: Entities such as AO "RANBAXY" in Russia serve as re-exporters. They import Ketorolac from India, possibly for further processing or repackaging, and then export the finished products to other markets. Their purchasing behavior is influenced by both domestic demand and the requirements of their export destinations, leading to variable order sizes and frequencies.

Each segment exhibits distinct procurement behaviors: distributors focus on steady supply to meet ongoing demand, contract manufacturers align purchases with production cycles, and re-exporters adjust orders based on both domestic and international market needs.

For the top five importing countries, the import regulations for Ketorolac are as follows:

The demand for Ketorolac in importing countries is driven by several factors:

1. Disease Prevalence: Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) used for short-term management of moderate to severe pain. The prevalence of conditions requiring pain management, such as post-operative pain and musculoskeletal disorders, contributes to its demand.

2. Government Healthcare Programs: Many countries have government-funded healthcare programs that include pain management medications. For instance, the inclusion of Ketorolac in national formularies ensures its availability in public healthcare facilities.

3. Universal Health Coverage Expansion: As countries expand their healthcare coverage, access to essential medicines like Ketorolac increases. This expansion leads to higher procurement volumes to meet the needs of a larger patient population.

4. WHO Essential Medicines List Procurement: Ketorolac is listed on the World Health Organization's Model List of Essential Medicines, indicating its importance in a basic health system. This listing encourages countries to procure and stock Ketorolac to meet essential healthcare needs.

5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender systems to ensure cost-effectiveness and supply reliability. The competitive nature of tenders can lead to increased demand for Ketorolac from suppliers who can meet quality and price criteria.

With 638 buyers across 124 countries, the global market for Ketorolac demonstrates significant demand, influenced by the factors mentioned above.

The importers of Ketorolac from India can be categorized into several key segments:

1. Distributors: Entities such as EVERSANA LIFE SCIENCE SERVICES and J. KNIPPER & COMPANY in the United States fall into this category. These organizations purchase Ketorolac in bulk to supply to various healthcare providers, pharmacies, and hospitals. Their buying behavior typically involves large-volume orders with a focus on maintaining a consistent supply chain to meet market demand.

2. Contract Manufacturers: Companies like BAXTER HEALTHCARE CORPORATION in the United States are contract manufacturers. They procure Ketorolac as an active pharmaceutical ingredient (API) to produce finished dosage forms under contract for other pharmaceutical companies. Their procurement patterns are aligned with production schedules and contractual obligations, often involving substantial quantities to ensure production efficiency.

3. Re-exporters: Entities such as AO "RANBAXY" in Russia serve as re-exporters. They import Ketorolac from India, possibly for further processing or repackaging, and then export the finished products to other markets. Their purchasing behavior is influenced by both domestic demand and the requirements of their export destinations, leading to variable order sizes and frequencies.

Each segment exhibits distinct procurement behaviors: distributors focus on steady supply to meet ongoing demand, contract manufacturers align purchases with production cycles, and re-exporters adjust orders based on both domestic and international market needs.

For the top five importing countries, the import regulations for Ketorolac are as follows:

The demand for Ketorolac in importing countries is driven by several factors:

1. Disease Prevalence: Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) used for short-term management of moderate to severe pain. The prevalence of conditions requiring pain management, such as post-operative pain and musculoskeletal disorders, contributes to its demand.

2. Government Healthcare Programs: Many countries have government-funded healthcare programs that include pain management medications. For instance, the inclusion of Ketorolac in national formularies ensures its availability in public healthcare facilities.

3. Universal Health Coverage Expansion: As countries expand their healthcare coverage, access to essential medicines like Ketorolac increases. This expansion leads to higher procurement volumes to meet the needs of a larger patient population.

4. WHO Essential Medicines List Procurement: Ketorolac is listed on the World Health Organization's Model List of Essential Medicines, indicating its importance in a basic health system. This listing encourages countries to procure and stock Ketorolac to meet essential healthcare needs.

5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through tender systems to ensure cost-effectiveness and supply reliability. The competitive nature of tenders can lead to increased demand for Ketorolac from suppliers who can meet quality and price criteria.

With 638 buyers across 124 countries, the global market for Ketorolac demonstrates significant demand, influenced by the factors mentioned above.